Skip to main content
. 2019 Dec 6;35(1):311–324. doi: 10.1080/14756366.2019.1699554

Figure 1.

Figure 1.

Reported pyrimidine-based anticancer molecules and design rationale for anticancer 2,5-diamino-4-pyrimidinol derivatives.